논문업데이트
Home >
Home. 최근뉴스. 논문업데이트
Prevention of allergic conjunctivitis in mice by a rice-based edible v…
페이지 정보
본문
Br J Ophthalmol. 2015 Jan 6. pii: bjophthalmol-2014-305842. doi: 10.1136/bjophthalmol-2014-305842. [Epub ahead of print]
Prevention of allergic conjunctivitis in mice by a rice-based edible vaccine containing modified Japanese cedar pollen allergens.
Author information
- 1Department of Ophthalmology and Visual Science, Kochi Medical School, Nankoku City, Kochi, Japan.
- 2Functional Transgenic Crop Research Unit, National Institute of Agrobiological Sciences, Tsukuba, Ibaraki, Japan.
Abstract
BACKGROUND/AIMS:
To determine whether oral immunotherapy with transgenic rice seeds expressing hypoallergenic modified antigens suppresses cedar pollen-induced allergic conjunctivitis by eliciting immune tolerance in mice.
METHODS:
BALB/c mice were fed once a day for 20 days with 220 mg of transgenic rice expressing modified Japanese cedar pollen allergens Cry j 1 and Cry j 2 or with non-transgenic rice seeds as a control. They were then sensitised with two intraperitoneal injections of Japanese cedar pollen in alum before challenge twice with pollen in eye drops. Twenty-four hours after the second challenge, the conjunctiva, spleen, and blood were isolated for histological analysis, cytokine production assays, and measurement of serum immunoglobulin E concentrations, respectively.
RESULTS:
The numbers of eosinophils and total inflammatory cells in the conjunctiva were significantly lower in mice fed the transgenic rice than in those fed non-transgenic rice. The clinical score evaluated at 15 min after antigen challenge was also significantly lower in mice fed the transgenic rice than in those fed non-transgenic rice. The serum concentrations of both total and allergen-specific immunoglobulin E were also significantly lower in mice fed the transgenic rice. Oral vaccination with transgenic rice resulted in significant down-regulation of the allergen-induced production of interleukin (IL)-2, IL-4, IL-5, IL-12p70, interferon-γ, and IL-17A by splenocytes.
CONCLUSIONS:
Oral immunotherapy with transgenic rice expressing modified Japanese cedar pollen allergens suppressed pollen-induced experimental allergic conjunctivitis in mice by eliciting immune tolerance. This novel prophylactic approach is potentially safe and effective for allergen-specific oral immunotherapy in allergic conjunctivitis.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
KEYWORDS:
Conjunctiva; Immunology; Ocular surface; Treatment other
-
- 이전글
- Innate responses to pollen allergens.
- 15.02.04
-
- 다음글
- The Effect of PM10 on Allergy Symptoms in Allergic Rhinitis Patients During Spring Season
- 15.02.04
댓글목록
등록된 댓글이 없습니다.
2026 © 한국 꽃가루알레르기 연구협회 (KoPAIF). All Rights Reserved.
